The Cosmetic Product Safety Report: Why a Korean Test Certificate Is Not One

2 June 2026 · The Glow Trade

An importer preparing her first direct shipment asks the Korean manufacturer for the safety documentation. Back comes a polished PDF: a certificate of analysis with a gold border, a stability test summary, a patch-test result from a Korean lab, and a letter saying the product is safe and sold all over the world. She forwards it to the EU safety assessor she has engaged, and the reply is one line: this is supporting material, not a safety report; we start from the formulation.

The gap between those two documents is the gap between the Korean system and the EU one, and it is the single most expensive misunderstanding in direct import, because the EU document is signed work by a specific professional, per product, and it cannot be downloaded from anyone's portal.

The short version

Before any cosmetic is placed on the EU market, the Responsible Person must ensure a safety assessment has been performed and a Cosmetic Product Safety Report drawn up (Article 10(1) of Regulation (EC) No 1223/2009).
The CPSR follows Annex I: part A assembles the safety data, part B is the assessment and conclusion, signed by an assessor whose qualifications the regulation defines. Korean certificates, MFDS documents and lab reports feed part A; they do not replace part B.
Vendor pricing for the assessment work runs in the low hundreds of euros per product and up, scaling with SKU count, which is why the economics of direct import break for broad assortments.

What the CPSR is made of

Annex I of the regulation splits the report into two parts. Part A, cosmetic product safety information, gathers the inputs: the quantitative and qualitative composition, physical and chemical characteristics, microbiological quality, impurities and traces, the characteristics of the packaging material, normal and reasonably foreseeable use, exposure per ingredient, the toxicological profile of the substances, and undesirable effects observed. This is where the Korean manufacturer's documents go: the formulation, the COAs, the stability and challenge tests, the GMP statement. A good manufacturer makes part A possible; nobody but the manufacturer can.

Part B, the cosmetic product safety assessment, is the judgement: the assessor's conclusion on whether the product is safe under normal and reasonably foreseeable use, the reasoning, the warnings that must go on the label, and the assessor's name, address and signature with proof of qualification. The regulation sets the bar for who may sign: a person with a defined scientific education and competence in toxicology-adjacent assessment. Part B cannot be delegated to the factory, translated from a Korean document, or bought as a template, because it is a professional opinion about this exact formulation at these exact concentrations.

Why the Korean paperwork does not convert

Korea runs its own serious cosmetics regime, and functional cosmetics there go through real MFDS review. The documents that come out of that system prove the product passed Korean requirements, under Korean rules, for the Korean market. The EU question is different: is this formulation safe under the EU's annexes, which ban and restrict different substances, at different limits, with different required warnings, and is the assessment signed by someone the EU system recognises?

Two consequences fall out of that. First, a formulation can be fully legal in Korea and still need reformulation or label changes for the EU, which is the everyday reality behind ingredients allowed in Korea but restricted in the EU. Second, even for a perfectly EU-clean formulation, part B still has to happen: someone qualified has to assess and sign. The MFDS certificate is evidence in part A. It is never part B.

What it costs and why the assortment maths breaks

The assessment is professional services work, and pricing follows the services market. Vendor quotes in 2026 cluster around the low hundreds of pounds or euros per product for the CPSR work, with Responsible-Person service packages that bundle notification and file-keeping running into the low thousands per year for a couple of SKUs. Treat any specific figure as a quote to be verified, not a tariff. The shape matters more than the number: the cost is per SKU and recurring, so it is tolerable for an importer with five strategic products and fatal for a retailer who wants to test forty Korean lines a year.

That shape is the mechanical reason broad K-beauty assortments in Europe live with wholesalers. The wholesaler spreads the same per-SKU compliance build across hundreds of retail customers; the direct-importing retailer carries it alone. It is the deepest line item in the true cost of importing, and the role that sits behind all of it is explained in who the Responsible Person is. The file the CPSR lives inside, who holds it and what you may ask for, is the subject of the PIF article.

Questions buyers ask

The brand says their product is "sold in the EU already". Does a CPSR exist?

If the product is genuinely and compliantly on the EU market, someone has notified it in the CPNP and a Responsible Person holds a file containing a CPSR. The question is whether that cover extends to your purchase. A notification by one Responsible Person does not automatically cover every parallel import of the same product, and your supplier's claim is only as good as the chain between their stock and that notification. This is exactly the verification work in checking a product's notification before you buy.

Can I write or sign the safety assessment myself?

Only if you personally hold the qualifications the regulation defines for the assessor, which is a scientific education with the relevant assessment competence, not "I have sold cosmetics for ten years". In practice every small importer commissions the work. The sensible cost-control move is not self-signing; it is choosing a narrow assortment of strategic products to import directly and letting EU stock carry the long tail.

Do I need a new CPSR when the supplier changes the formula or the packaging?

The file must reflect the product as sold: relevant formulation changes require the safety information and assessment to be revisited, and even packaging changes can matter because packaging characteristics are part of the Annex I inputs. This is why importers ask Korean suppliers for change notification in writing, and why a supplier who reformulates silently is not a supplier, whatever their prices do.